Newer therapies in dermatophytosis
With the advent of newer drugs and formulations, the armamentarium to combat dermatophytosis is ever-expanding. However, we must be rational and scientific when choosing the drugs. This review is an attempt to summarise the recently approved and upcoming therapeutic options for dermatophytosis.
Main Authors: | Shreya Poddar, Anupam Das, Roderick James Hay, Uwe Wollina |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Indian Journal of Dermatology |
Subjects: | |
Online Access: | http://www.e-ijd.org/article.asp?issn=0019-5154;year=2023;volume=68;issue=5;spage=515;epage=519;aulast=Poddar |
Similar Items
-
Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis
by: Dhiraj Dhoot, et al.
Published: (2023-01-01) -
Comparative efficacy and safety of super-bioavailable itraconazole-130 mg once daily in obese and non-obese patients of glabrous tinea
by: Manjunath Shenoy, et al.
Published: (2023-01-01) -
Comparison of Efficacy and Safety between Super-bioavailable Itraconazole and Conventional Itraconazole in the Treatment of Tinea Infection of Glabrous Skin – A Randomised Observer-blinded Pilot Study
by: Liza Mohapatra, et al.
Published: (2023-09-01) -
Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial
by: Shenoy MM, et al.
Published: (2023-09-01) -
Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial [Corrigendum]
by: Shenoy MM, et al.
Published: (2023-09-01)